Skip to main content
/
DaVita Inc. (LON:0I7E)
London flag London · Delayed Price · Currency is GBP · Price in USD
140.47
+0.62 (0.45%)
At close: Apr 30, 2025

DaVita Revenue

In the year 2024, DaVita had annual revenue of $12.82B USD with 5.56% growth. DaVita had revenue of $3.29B in the quarter ending December 31, 2024, with 4.73% growth.

Revenue
$12.82B
Revenue Growth
+5.56%
P/S Ratio
0.80
Revenue / Employee
$168.63K
Employees
76,000
Market Cap
8.16B GBP

Revenue Chart

Created with Highcharts 11.4.8DaVita Revenue - Annual11.55B​11.55B11.62B​11.62B11.61B​11.61B12.14B​12.14B12.82B​12.82B20202021202220232024-3B5B8B10B13B
* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202412.82B675.40M5.56%
Dec 31, 202312.14B530.25M4.57%
Dec 31, 202211.61B-8.90M-0.08%
Dec 31, 202111.62B68.19M0.59%
Dec 31, 202011.55B162.13M1.42%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
GSK plc 31.38B
Haleon 11.23B
Smith & Nephew 4.64B
ConvaTec Group 1.83B
Hikma Pharmaceuticals 2.50B
HUTCHMED (China) 503.39M
Genus 671.60M
Revenue Rankings

DaVita News

More News